Aculife

What Aculife does

Aculife Healthcare Private Limited is an Ahmedabad-based, Nirma Limited–owned pharmaceutical manufacturer that produces and supplies a broad portfolio of sterile and specialty healthcare products to hospitals, clinics, and government health systems. The company has been associated with the Indian healthcare segment for over 30 years and reports supplying 1 in every 6 IV fluids and diluents consumed in India. It is one of only two Indian companies that manufacture the entire parenteral range of intravenous fluids, giving it a structurally scarce domestic production footprint. Its 501–1,000 employee base is concentrated at the corporate headquarters on Prahlad Nagar Corporate Road, Ahmedabad, Gujarat.

The company's product platform spans nine therapeutic categories: infusions (bottle and bag), injectables, critical care medicines including parenteral nutrition, ophthalmics, anesthesia (gaseous and injectable), respiratory products, dermatology and gel formulations, oral shots, and contact lens cleaning solutions. Underlying capabilities include state-of-the-art sterile manufacturing, complete-range parenteral production, and demonstrated surge logistics — most visibly the shipment of over 1.3 million IV bottles to Sri Lanka within 2 days during a healthcare crisis. The company is registered as a private limited entity in Gujarat, India, with a wholly-owned subsidiary relationship to Nirma Limited; no external venture or private equity funding is disclosed.

Commercially, Aculife operates a B2B model selling directly to Indian healthcare providers and to international government health systems, with no publicly disclosed pricing. Distribution is direct to hospitals and institutions domestically, with episodic cross-border export capability. Its stated positioning is "affordable healthcare for all," and growth is supported by a 2026 third-party identification as one of 25 leading companies in the global parenteral nutrition market — a segment projected to grow from USD 7.94 billion in 2024 to USD 14.91 billion by 2035.

Name

Aculife

Legal name

Aculife Healthcare Private Limited

Website

https://aculife.co.in

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Aculife Healthcare Private Limited is an Ahmedabad-based pharmaceutical manufacturer supplying IV fluids, injectables, critical care medicines, ophthalmics, anesthesia, respiratory, dermatology, oral shots, and contact lens solutions to hospitals, healthcare institutions, and government health systems in India and select international markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing (Sterile Injectables & IV Fluids)

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hand Hygiene & Skin Antisepsis (Soaps, Sanitizers, Surgical Scrubs, CHG Prep) (HLAHANAE)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care) (CRADAMAB)

Keywords

• Pharmaceutical manufacturing
• Intravenous fluids
• Parenteral nutrition
• Sterile injectables
• Critical care medicines

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Aculife generates revenue through the manufacture and sale of pharmaceutical healthcare products including IV fluids, injectables, critical care medicines, ophthalmics, anesthesia products, respiratory products, dermatology products, oral shots, and contact lens cleaning solutions. The company operates as a B2B supplier to healthcare providers and institutions.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Aculife Healthcare Private Limited is a B2B pharmaceutical manufacturer that produces and supplies a wide spectrum of healthcare products including intravenous (IV) infusions in bottle and bag formats, sterile injectables, critical care medicines (including parenteral nutrition), ophthalmics, anesthesia products (gaseous and injectable), respiratory products, dermatology and gel formulations, oral shots, and contact lens cleaning solutions. The company is one of only two Indian manufacturers producing the entire parenteral range of IV fluids, supplying 1 in every 6 IV fluids and diluents in India.

Product overview

Aculife Healthcare Private Limited is a pharmaceutical company offering a wide spectrum of healthcare products across multiple therapeutic categories. The company operates a multi-product portfolio including Infusions (Bottles and Bags), Injectables, Critical Care Medicines (Including Parenteral Nutrition), Ophthalmics, Anaesthesia (Gaseous and Injectable), Respiratory Products, Dermatology & Gel Segment, Oral Shots, and Contact Lens Cleaning Solutions. Aculife is one of only two Indian companies manufacturing the entire parenteral range of intravenous fluids, and supplies 1 in every 6 IV fluids and diluents in India. The company positions itself as a comprehensive healthcare solutions provider with a focus on affordability and quality.

Differentiator

Problem solved

Functional benefit

Products and services

• Infusions (Bottle and Bag) Intravenous infusion solutions available in both bottle and bag formats for fluid and electrolyte administration in clinical settings.
• Injectables Sterile injectable pharmaceutical products for various therapeutic applications in hospital and clinical use.
• Critical Care Medicines (Including Parenteral Nutrition) Intensive care pharmaceutical products including parenteral nutrition solutions for patients requiring nutritional support via intravenous administration.
• Ophthalmics Eye care pharmaceutical products for the treatment of various ophthalmic conditions.
• Anaesthesia (Gaseous and Injectable) Anesthetic agents available in both gaseous and injectable forms for surgical and medical procedures.
• Respiratory Products Pharmaceutical products designed for respiratory care and treatment of respiratory conditions.
• Dermatology & Gel Segment Topical dermatological products and gel-based pharmaceutical formulations for skin conditions.
• Oral Shots Concentrated oral liquid pharmaceutical preparations in shot format for various therapeutic applications.
• Contact Lens Cleaning Solutions Ophthalmic solutions specifically formulated for cleaning and disinfecting contact lenses.

Quantifiable outcome

• 1 in every 6 IV fluids & diluents in India supplied by Aculife
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Hospira (Pfizer): Hospira, now part of Pfizer, is a global leader in sterile injectable pharmaceuticals including IV solutions and anesthesia. As a much larger multinational with broader therapeutic coverage, it competes with Aculife but in many more product categories beyond IV fluids.
• Abbott Laboratories: Abbott operates a global pharmaceutical and nutritional products business with significant presence in IV nutrition (parenteral nutrition), injectables, and hospital products. Comparable to Aculife in its critical care/parenteral nutrition offerings but as a much larger, multi-specialty incumbent.
• Otsuka Pharmaceutical: Otsuka's pharmaceutical division manufactures IV solutions, infusion therapies, and clinical nutrition products, particularly across Asian markets. It competes with Aculife in IV fluids but as a much larger diversified Japanese pharma company.

Direct peers

• Claris Lifesciences: Claris Lifesciences is an India-headquartered sterile injectable pharmaceutical manufacturer with a portfolio of IV fluids, infusions, and critical care products. As a domestic Indian competitor with overlapping product categories, it competes head-to-head with Aculife in the same hospital channels.
• Fresenius Kabi: Fresenius Kabi is the global market leader in clinical nutrition and IV fluids, with a comprehensive parenteral nutrition portfolio that directly competes with Aculife's critical care and parenteral nutrition offerings. Both companies manufacture sterile injectable solutions and target hospitals and ICU settings worldwide.
• Baxter International: Baxter is one of the world's largest manufacturers of IV solutions, injectable pharmaceuticals, and parenteral nutrition products, making it the most direct global competitor to Aculife's infusions and injectables portfolio. Both supply hospitals with sterile fluids and critical care medicines via B2B channels.
• B. Braun Melsungen: B. Braun is a leading German manufacturer of IV fluids, infusion solutions, and sterile injectable pharmaceuticals with global hospital distribution. It directly competes with Aculife across intravenous solutions, injectables, and anesthesia product lines.
• Piramal Pharma: Piramal Pharma is a major Indian pharmaceutical conglomerate with sterile injectables, IV fluids, and anesthesia capabilities via its critical care division. It is one of the most comparable Indian-headquartered peers to Aculife in scale, product mix, and B2B hospital sales model.

Emerging players

• Polymedicure: Polymedicure is an Indian medical device company with IV infusion sets, IV cannulas, and related hospital consumables. While focused on devices rather than injectables themselves, it operates in adjacent categories of IV administration and shares Aculife's B2B hospital sales channel in India.
• Amsino Pharma: Amsino is a privately-held manufacturer of sterile injectables, IV solutions, and medical devices operating globally with significant Indian manufacturing presence. It overlaps with Aculife in IV fluids and sterile injectables, particularly in export markets and emerging economies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/aculife-healthcare-private-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aculife